Where, why, and how life science organizations should focus on patient engagement throughout the treatment development lifecycle. Meghan Lynch & Maren Mellen Recent advancements in treatment technology have enabled Life Science organizations to radically reimagine the patient experience. Personalized medicine, gene therapy, and AI have equipped providers with new patient…